Junshi Biosciences Announces Toripalimab as Perioperative Treatment for Operable NSCLC Patients Met Primary Endpoint in Phase 3 Clinical Study
Globe Newswire18-01-2023, 10:56
HashKey Global Announces 3rd Lock to Earn Launch With XRADERS (XR) - Earn from 142,000 XR and 120,000 USDT ! 11-07-2024, 14:53